As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with
RWJBarnabas Health
, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
|
|
|
Rutgers Cancer Institute Radiation Oncology Leader Receives Prestigious National Award
|
|
|
|
Bruce G. Haffty, MD
, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as this year’s Gold Medal Award recipient by the American Society for Radiation Oncology (ASTRO), the world’s largest radiation oncology organization. Dr. Haffty, who is also Chair of Radiation Oncology at Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School, is heralded for his significant accomplishments in the field.
Learn more
|
|
Your Cancer Care is Too Important to Wait: Fostering a Safe Environment for Patients
|
|
|
|
Minimizing exposure to COVID-19 doesn’t require sacrificing cancer care or preventive services. Rutgers Cancer Institute of New Jersey experts share more about safeguards that have been put in place at our facilities. These include screening for symptoms, strict social distancing measures, limiting visitors, mandating face coverings and enhanced cleaning measures to ensure that patients can continue to receive the exceptional care they’ve come to expect, close to home.
Learn more
|
|
Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
|
|
|
|
Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University, our NCI-designated Comprehensive Cancer Center consortium partner, have identified a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia. Rutgers Cancer Institute resident researcher
Daniel Herranz Benito, PhD
, assistant professor of pharmacology at Rutgers Robert Wood Johnson Medical School, shares more about the importance of these findings.
Learn more
|
|
Collaborating to Enhance Decision Making in Hodgkin Lymphoma
|
|
|
|
Rutgers Cancer Institute researchers along with global colleagues are exploring ways to improve clinical decision making for Hodgkin lymphoma patients.
Andrew M. Evens, DO, MSc, FACP
, associate director for clinical services and director of the Lymphoma Program at Rutgers Cancer Institute of New Jersey and medical director of oncology services at RWJBarnabas Health, shares information about the creation of an international consortium that contributed to work recently presented at the virtual American Society for Clinical Oncology Annual Meeting.
Learn more
|
|
Celebrating Men’s Health Month
|
|
|
|
June is Men’s Health Month, a national recognition that raises awareness about health care for men. It is also the month during which we celebrate Father’s Day. In celebration of these observances,
Biren Saraiya, MD
, medical oncologist in the Urologic Oncology Program at Rutgers Cancer Institute of New Jersey and assistant professor of medicine at Rutgers Robert Wood Johnson Medical School
shares information on cancer screenings and other important tips to encourage dad to lead a healthy lifestyle all year round.
Learn more
|
|
|
|
|
|
|
